Learning Objectives:

Describe surrogate endpoints and their relevance in neoadjuvant immunotherapy trials
Discuss current paradigm for treatment of immune related adverse events

Session date: 
11/06/2023 - 12:00pm to 1:00pm CST
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jacobi Hines, MD